IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 71 filers reported holding IMMUNIC INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350,889 | -20.1% | 238,700 | +36.5% | 0.00% | -25.0% |
| Q2 2023 | $438,999 | +121.5% | 174,900 | +31.5% | 0.00% | +100.0% |
| Q1 2023 | $198,170 | -39.9% | 133,000 | +27.4% | 0.00% | -33.3% |
| Q3 2022 | $330,000 | -6.5% | 104,400 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $353,000 | -61.5% | 101,700 | +25.6% | 0.00% | -62.5% |
| Q1 2022 | $916,000 | +69.9% | 81,000 | +43.9% | 0.01% | +60.0% |
| Q4 2021 | $539,000 | +11.8% | 56,300 | +3.5% | 0.01% | 0.0% |
| Q3 2021 | $482,000 | -22.8% | 54,400 | +6.9% | 0.01% | -28.6% |
| Q2 2021 | $624,000 | -7.0% | 50,900 | +20.9% | 0.01% | -12.5% |
| Q1 2021 | $671,000 | +10.9% | 42,100 | +6.3% | 0.01% | 0.0% |
| Q4 2020 | $605,000 | -64.3% | 39,600 | -56.7% | 0.01% | -75.0% |
| Q3 2020 | $1,697,000 | +95.1% | 91,400 | +27.3% | 0.03% | +166.7% |
| Q2 2020 | $870,000 | – | 71,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |